Keywords anthranilamide - acetophenones - quinazolinones - oxidative annulation - Michael addition - transition-metal-free synthesis - microwave irradiation
In recent past, dimethyl sulfoxide (DMSO) has become a versatile entity in organic synthesis. The role of DMSO started as a low-toxic, aprotic, polar solvent.[1 ] Its application is further extended to an oxidizing agent in many organic transformations such as Kornblum oxidation, Swern oxidation, Pfitzner–Moffatt oxidation, and Corey–Chaykovsky reaction.[2 ] More recently, DMSO is employed as a source of several synthons such as –CH3 ,[3 ] –CH2 –,[4 ] –CN,[5 ] –SMe,[6 ] etc. Such transformations play a vital role in the synthesis of several pharmaceuticals, agrochemicals, and life science materials.
Figure 1 Biologically active quinazolinones
N-Containing heterocyclic compounds are the most profuse and integral scaffolds that occur ubiquitously in a variety of synthetic drugs, bioactive natural products, pharmaceuticals, and agrochemicals.[7 ] The quinazolinone skeleton containing frameworks are one such class of biologically privileged scaffolds that occur in several natural alkaloids.[8 ] Literature study reveals that quinazolinones are also functional in the construction of several medicinally active entities (Figure [1 ]) such as antibacterial, analgesic, anti-inflammatory, antifungal, antimalarial, antihypertensive, CNS depressant, anticonvulsant, antihistaminic, antiparkinsonism, antiviral, and anticancer activities.[9 ]
Owing to their structural and biological importance quinazolinones have become the interest of several researchers. Synthesis of 3-(3-oxo-3-phenylpropyl)quinazolin-4(3H )-one was achieved by alkylation of 4(3H )-quinazolinone with 3-halo-1-phenylpropan-1-one.[10 ] Another research group established its synthesis from N -heteroarenes, methyl ketones using DMPA as one carbon source using copper catalyst.[11 ]
Furthermore, a very recent report demonstrated the synthesis of 3-(3-oxo-3-phenylpropyl)quinazolin-4(3H )-one from readily available starting materials using a conventional synthetic method.[12 ] All the above-mentioned methods have few drawbacks of preparation of reaction intermediates, use of metal catalyst, and long reaction time. To overcome all the aforesaid inadequacies, there is a need to develop a new synthetic strategy. Condensation of aryl methyl ketones with anthranilamide in the presence of a carbon source could be one such solution. In the literature two independent reports proposed iodine-[13 ] and sulfur-promoted[14 ] synthesis of 2-aroylquinazolin-4(3H )-one from anthranilamide and acetophenones, respectively. More recently, iodine-mediated oxidative synthesis of 2-aryl quinazolin-4(3H )-one,[15 ] and Hβ-zeolite-catalyzed synthesis of 2,3-dihydroquinazolin-4(1H )-ones[16 ] were reported from the same starting materials. On the other hand, DMSO used as one carbon source for the K2 S2 O8 -mediated oxidative annulation reaction of anthranilamides (Scheme [1a ])[17a ] and homologation of the acetophenones (Scheme [1a ])[17b ] is described in independent reports.
Scheme 1 Previous work and present approach
Since last three decades, many green protocols have been developed using microwave (MW) chemistry with significant benefits of drastically reduced reaction time, homogenous heat distribution, better yields, etc.[18 ] In continuation to our research efforts in the development of a greener protocol for the organic synthesis[19 ] coupled with the significance of microwave chemistry, we have developed an efficient protocol for the synthesis of 3-oxopropyl quinazoline-4(3H )-one. Herein, we report (Scheme [1 ]) a one-pot microwave-assisted synthesis of 3-(3-oxo-3-arylpropyl) quinazolinones from readily available aryl methyl ketones and anthranilamide in the presence of DMSO, an oxidant, and an additive (Scheme [1b ]).
DMSO is utilized not only as a solvent but also as a source of two carbons (methine ( =CH–) and methylene (–CH2 –)), in which one carbon inserted between two nitrogen atoms of anthranilamide forming quinazolin-4(3H )-one and the other carbon participates in the homologation of aryl methyl ketones further forming a bridge between quinazolinone and aryl methyl ketones. It is noteworthy to mention that these reactions take very less time compared to conventional synthetic process without any catalyst loading thereby making this method highly valuable.
Considering the previous reports, it is evident that aryl methyl ketones upon reaction with K2 S2 O8 and CH3 COONa would result in the formation of 4a .[17a ] On the other hand anthranilamide resulted in the formation of 3a under similar reaction conditions.[17b ] We started our investigation by reacting anthranilamide (1a ) with readily available acetophenone 2a as model substrates in the presence of K2 S2 O8 and CH3 COONa in the presence of DMSO. The details are summarized in Table [1 ].
Table 1 Preliminary Experiments and Optimizationa
Entry
Oxidant
Base
Temp
(℃)
Time (h)
Yield (%) of
3a
Yield (%) of 4a
Yield (%) of 5a
1b
K2 S2 O8
CH3 COONa
120
16
0
0
78
2
K2 S2 O8
CH3 COONa
100
0.5
20
0
0
3
K2 S2 O8
CH3 COONa
120
0.5
40
0
0
4
K2 S2 O8
CH3 COONa
140
1
45
10
20
5
K2 S2 O8
CH3 COONa
140
2
24
16
52
6
K2 S2 O8
CH3 COONa
160
2
0
0
81
7
K2 S2 O8
DABCO
160
2
25
12
55
8
K2 S2 O8
DBU
160
2
trace
trace
0
9
K2 S2 O8
Et3 N
160
2
trace
0
0
10
(NH4 )2 S2 O8
CH3 COONa
160
2
0
0
0
11
KHSO4
CH3 COONa
160
2
0
0
0
12
(NH4 )OAc
CH3 COONa
160
2
0
0
0
a Reaction was performed using 1a (1.0 mmol), 2a (1.1 mmol), DMSO (2.0 mL), oxidant (2.5 mmol), base (2.5 mmol) under microwave irradiation.
b Reaction under conventional heating conditions.
Conventional heating of this reaction was fruitful in delivering the product 5a after 16 h at 120 ℃ (Table [1 ]
, entry 1). With a vision to reduce the reaction time and make use of the microwave irradiation, we tried to perform the reaction at 100 °C for 0.5 h in a microwave reactor, which resulted in trace amount of intermediate 3a but no formation of required compound 5a (Table [1 ], entry 2). In an attempt to achieve the required results, we tried to increase the reaction temperature to 120 ℃ (Table [1 ], entry 3).
Unfortunately, these conditions also could not give us the required results. Further we increased the reaction time to 1 h simultaneously increasing the temperature to 140 ℃ which resulted in trace amount of 5a along with intermediates 3a and 4a (Table [1 ], entry 4). Leaving the reaction for one more hour gave us a considerable amount of 5a with traces of other intermediates (Table [1 ], entry 5). Delightfully, we could succeed in optimizing the reaction conditions when the temperature was raised to 160 ℃ for 2 h, with significant increase in the yield of 5a without any intermediate left unreacted (Table [1 ], entry 6). Furthermore, we tried to explore the reaction by using different base, such as DABCO (Table [1 ], entry 7), DBU (Table [1 ], entry 8), and Et3 N (Table [1 ], entry 9), but none of these improved the results. Changing the oxidant (Table [1 ], entries 10, 11) gave 0% yield of 5a . All these reactions (Table [1 ], entries 2–12) were microwave assisted.
With the optimized reaction conditions to broaden the scope of this microwave-assisted one-pot tandem reaction, we performed the reaction with different aryl methyl ketones having both electron-donating (EDG) and electron-withdrawing (EWG) groups to study the electronic effect of various electron-rich and electron-deficient substituents. Surprisingly, both the groups were well tolerated. As cited in Table [2 ], aryl methyl ketones containing various electron-donating groups such as alkyl (2b –f ) and alkoxy (2g –h ) readily delivered the corresponding 3-(3-oxo-3-arylpropyl) quinazolinones (5b –h ) with very good yields (75–84%). Ketones with free hydroxy and phenoxy substitution (2j –k ) also tolerated the reaction conditions smoothly and gave good yields. Furthermore, several halo-substituted aryl methyl ketones such as 4-chloro (2l ), 3-chloro (2m ), 4-bromo (2o ), 3-bromo (2p ), 4-fluoro (2q ), and 3,4-dichloro (2n ) provided the desired products (5l –q ) with moderate to good yields (67–74%). To our delight, strong electron-withdrawing groups such as 3-CF3 (2r ) and 4-NO2 (2s ) also participated efficiently in the reaction and furnished the corresponding products (5r –s ) in decent yields. Pleasantly, aryl methyl ketone with both EDG and EWG (2t ) also provided the expected product 5t with a moderate yield. Aryl methyl ketones such as 4-phenyl acetophenone (2u ) also furnished the expected product 5u with good yield. To examine the substitution on anthranilamide, we conducted reactions with 5-chloro anthranilamide (1b ) and 5-fluoro anthranilamide (1c ) also producing the products 5ba and 5ca , respectively, with moderate yields. This shows that the method can tolerate a wide range of substitutions.
Table 2 Scope with Different Acetophenonesa
Entry
R1
R2
Yield (%)
1
5a
H
H
81
2
5b
H
2-methyl
78
3
5c
H
4-methyl
80
4
5d
H
3,4-dimethyl
77
5
5e
H
4-ethyl
75
6
5f
H
4-tert -butyl
79
7
5g
H
3-methoxy
84
8
5h
H
3,4,5-trimethoxy
80
9
5i
H
4-hydroxy
78
10
5j
H
3-methoxy-4-hydroxy
76
11
5k
H
4-phenoxy
74
12
5l
H
4-chloro
74
13
5m
H
3-chloro
72
14
5n
H
3,4-dichloro
70
15
5o
H
4-bromo
69
16
5p
H
3-bromo
72
17
5q
H
4-fluoro
67
18
5r
H
3-trifluoromethyl
75
19
5s
H
4-nitro
68
20
5t
H
3-methoxy-4-nitro
70
21
5u
H
4-phenyl
77
22
5ba
5-chloro
H
72
23
5ca
5-fluoro
H
75
a Reaction was performed using 1a (1.0 mmol), 2a (1.1 mmol), DMSO (2.0 mL), oxidant (2.5 mmol), base (2.5 mmol), microwave irradiation, 2 h, 160 ℃.
The method was further explored with heteroaromatic methyl ketones (Figure [2 ]) like 2-acetyl furan (2v ) and 2-acetyl thiophene (2w ); polyaromatic 2-acetyl naphthalene (2y ) and 9-acetyl anthracene (2z ), all of which contributed to the anticipated products 5v –z with good yields. Hence, it is unambiguous that the protocol is not affected by the substitutions of aryl methyl ketones, making the method versatile. To expand the scope of ketone, we conducted a reaction with 3-methylbutan-2-one (2aa ) and anthralinamide (1a ) which unfortunately could not furnish the expected product 5aa .
Figure 2 Scope with few heteroaryl/polyaromatic ketones. Reaction was performed using 1a (1.0 mmol), 2a (1.1 mmol), DMSO (2.0 mL), oxidant (2.5 mmol), base (2.5 mmol) microwave irradiation, 2 h, 160 ℃.
In order to further understand the reaction mechanism, we carried out a series of control experiments (Scheme [2 ]). Initially, when our desired product 5a was treated with a strong base like t -BuOK, it underwent β-elimination and furnished two reactive intermediates 3a and 4a with quantitative yields (Scheme [2 ], A). This indicates the generation of phenyl vinyl ketone (4a ) from acetophenone and quinazolin-4(3H )-one (3a ) from anthranilamide. On this basis, 3a was reacted with 4a in DMSO without any oxidant and additive (Scheme [2 ], B). Pleasingly, 5a was formed in good yield. Conducting a reaction between 1a and 2a under standard reaction conditions in the absence of CH3 COONa (Scheme [2 ], D) resulted in a reduced yield, illustrating that CH3 COONa affects product yield. The absence of K2 S2 O8 did not allow the reaction to proceed (Scheme [2 ], C). This evidently shows the essential role of K2 S2 O8 . Furthermore, we carried out deuterium-labelling experiments to verify the carbon source by treating 1a with 2a in DMSO-d
6 under standard reaction conditions which gave 5a-d3
in 75% yield (Scheme [2 ], E). 1 H NMR analysis further revealed 100% deuteration at the C-2 position and at the terminal carbon of the phenyl vinyl ketone which justifies DMSO as two-carbon source.
Scheme 2 Control experiments
Scheme 3 A plausible reaction pathway
Based on the literature and considering the mechanistic and control experiments, a plausible mechanism has been designed as shown in Scheme [3 ]. Initially, K2 S2 O8 activates DMSO to form sulfonium ion A . Then anthranilamide (1a ) condenses with A to furnish intermediate B , which on further elimination of methanethiol forms C , which upon intramolecular annulation gives D . This upon oxidation in the presence of K2 S2 O8 affords 3a . Subsequently, aryl ketones react with sulfonium ion A to form E , leading to the generation of α,β-unsaturated carbonyl compound 4a by eliminating methanethiol. Finally, 3a undergoes Michael addition with 4a to deliver the desired product 5a .
In conclusion, we have expounded a microwave-irradiated transition-metal-free tandem approach for the synthesis of 3-(3-oxo-3-arylpropyl) quinazolinones from readily available anthranilamide and various substituted aryl methyl ketones in the presence of K2 S2 O8 and DMSO via cyclization of anthranilamide followed by aza-Michael addition with homologated acetophenones. In this protocol, DMSO is acting as a carbon source to form the 3-(3-oxo-3-arylpropyl) quinazolinones. Microwave irradiation adds the benefit of reduced reaction time drastically and homogenous heat distribution. Notably, this method does not afford any side products. Considering the wide availability of the starting materials, broad substrate scopes, and operational simplicity, fast reaction, the present method provides an attractive protocol for the synthesis of the 3-(3-oxo-3-arylpropyl) quinazolinones.
All solvents were dried by a standard literature procedure. Crude products were purified by column chromatography on silica gel of 60–120 or 100–200 mesh. Thin-layer chromatography (TLC) plates were visualized by exposure to ultraviolet light at 254 nm and by exposure to iodine vapors and/or by exposure to methanolic acidic solution of p -anisaldehyde followed by heating (<1 min) on a hot plate (ca. 250 °C). Organic solvents were concentrated on rotary evaporator at 35–40 °C. Melting points (mp) were measured on Buchi B-540. 1 H and 13 C NMR (proton-decoupled) spectra were recorded in CDCl3 and/ DMSO solvent on 300, 400, or 500 MHz NMR spectrometer. Chemical shifts (δ) were reported in parts per million (ppm) with respect to TMS as an internal standard. Coupling constants (J ) are quoted in hertz (Hz). Mass spectra and HRMS were recorded on a mass spectrometer by electrospray ionization (ESI) or atmospheric pressure chemical ionization (APCI) technique. All the reactions were carried out in Anton Paar microwave synthetic reactor Monowave 200.
General Procedure for the Synthesis of 5
General Procedure for the Synthesis of 5
A mixture of anthranilamides (1a –c , 1.0 mmol), acetophenones (2a –z , 1.1 mmol), DMSO (2 mL), K2 S2 O8 (2.5 mmol), and sodium acetate (2.5 mmol) were added to a 5 mL microwave vial. The vial is sealed and stirred in the microwave reactor at 160 ℃ for 2 h. The reaction mixture was quenched with ice-cold water, extracted with EtOAc and water. Further, the organic layer was concentrated and purified by column chromatography on silica gel (EtOAc/hexane) to afford the pure products 5a –z , 5ba –ca .
3-(3-Oxo-3-phenylpropyl)quinazolin-4(3H )-one (5a)
3-(3-Oxo-3-phenylpropyl)quinazolin-4(3H )-one (5a)
Yield 0.165 g, 81%; off-white solid; mp 105–107 ℃.
1 H NMR (400 MHz, CDCl3 ): δ = 8.39 (s, 1 H), 8.29 (dd, J = 8.0, 0.9 Hz, 1 H), 7.94 (dd, J = 5.2, 3.3 Hz, 2 H), 7.72 (ddd, J = 9.2, 7.4, 1.3 Hz, 2 H), 7.58–7.54 (m, 1 H), 7.51–7.41 (m, 3 H), 4.43 (t, J = 5.9 Hz, 2 H), 3.60 (t, J = 5.9 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 197.52, 161.46, 148.19, 147.72, 136.14, 134.29, 133.70, 128.74, 128.10, 127.55, 127.19, 126.42, 122.02, 42.84, 36.88.
HRMS (ESI): m/z calcd for C17 H15 N2 O2 [M + H]: 279.1134; found: 279.1134.
3-[3-Oxo-3-(o -tolyl)propyl]quinazolin-4(3H )-one (5b)
3-[3-Oxo-3-(o -tolyl)propyl]quinazolin-4(3H )-one (5b)
Yield 0.167 g, 78%; pale white solid; mp 119–123 ℃.
1 H NMR (400 MHz, CDCl3 ): δ = 8.36 (s, 1 H), 8.30 (dd, J = 8.0, 0.9 Hz, 1 H), 7.76–7.66 (m, 3 H), 7.49 (ddd, J = 8.2, 6.8, 1.5 Hz, 1 H), 7.40–7.35 (m, 1 H), 7.23 (d, J = 7.5 Hz, 2 H), 4.41 (t, J = 6.0 Hz, 2 H), 3.53 (t, J = 6.0 Hz, 2 H), 2.50 (s, 3 H).
13 C NMR (101 MHz, CDCl3 ): δ = 200.70, 161.44, 148.21, 147.64, 139.07, 136.28, 134.30, 132.31, 132.15, 129.15, 127.57, 127.21, 126.47, 125.90, 122.04, 43.01, 39.27, 21.80.
HRMS (ESI): m/z calcd for C18 H17 N2 O2 [M + H]: 293.1290; found: 293.1287.
3-[3-Oxo-3-(p -tolyl)propyl]quinazolin-4(3H )-one (5c)
3-[3-Oxo-3-(p -tolyl)propyl]quinazolin-4(3H )-one (5c)
Yield 0.171 g, 80%; pale yellow solid; mp 137–140 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.34 (s, 1 H), 8.19 (d, J = 8.0 Hz, 1 H), 7.78–7.72 (m, 2 H), 7.64 (s, 2 H), 7.40 (s, 1 H), 7.14 (d, J = 7.2 Hz, 2 H), 4.40–4.22 (m, 2 H), 3.48 (t, J = 5.4 Hz, 2 H), 2.29 (s, 3 H).
13 C NMR (101 MHz, CDCl3 ): δ = 197.13, 161.41, 147.96, 147.88, 144.59, 134.34, 133.70, 129.39, 128.21, 127.26, 127.24, 126.44, 121.93, 42.99, 36.72, 21.69.
HRMS (ESI): m/z calcd for C18 H17 N2 O2 [M + H]: 293.1290; found: 293.1287.
3-[3-(3,4-Dimethylphenyl)-3-oxopropyl]quinazolin-4(3H )-one (5d)
3-[3-(3,4-Dimethylphenyl)-3-oxopropyl]quinazolin-4(3H )-one (5d)
Yield 0.173 g, 77%; white solid; mp 125–128 °C.
1 H NMR (300 MHz, CDCl3 ): δ = 8.31 (s, 1 H), 8.21 (dd, J = 8.0, 0.7 Hz, 1 H), 7.69–7.57 (m, 4 H), 7.41 (ddd, J = 8.1, 6.6, 1.7 Hz, 1 H), 7.11 (d, J = 7.8 Hz, 1 H), 4.35 (t, J = 5.9 Hz, 2 H), 3.49 (t, J = 5.9 Hz, 2 H), 2.21 (d, J = 3.5 Hz, 6 H).
13 C NMR (126 MHz, CDCl3 ): δ = 197.37, 161.46, 148.20, 147.76, 143.34, 137.10, 134.25, 134.12, 129.94, 129.22, 127.54, 127.14, 126.40, 125.82, 122.03, 42.91, 36.76, 20.09, 19.76.
HRMS (ESI): m/z calcd for C19 H19 N2 O2 [M + H]: 307.1447; found: 307.1446.
3-[3-(4-Ethylphenyl)-3-oxopropyl]quinazolin-4(3H )-one (5e)
3-[3-(4-Ethylphenyl)-3-oxopropyl]quinazolin-4(3H )-one (5e)
Yield 0.168 g, 75%; white solid; mp 92–94 °C.
1 H NMR (500 MHz, CDCl3 ): δ = 8.30 (s, 1 H), 8.19 (dd, J = 8.0, 1.0 Hz, 1 H), 7.79–7.75 (m, 2 H), 7.66–7.59 (m, 2 H), 7.39 (ddd, J = 8.2, 6.8, 1.5 Hz, 1 H), 7.16 (d, J = 8.4 Hz, 2 H), 4.33 (s, 2 H), 3.48 (t, J = 6.0 Hz, 2 H), 2.59 (q, J = 7.6 Hz, 2 H), 1.14 (t, J = 7.6 Hz, 3 H).
13 C NMR (101 MHz, CDCl3 ): δ = 197.14, 161.41, 150.74, 148.12, 147.78, 134.25, 133.93, 128.32, 128.22, 127.49, 127.14, 126.40, 122.01, 42.89, 36.76, 28.97, 15.15.
HRMS (ESI): m/z calcd for C19 H19 N2 O2 [M + H]: 307.1447; found: 307.1446.
3-{3-[4-(tert -Butyl)phenyl]-3-oxopropyl}quinazolin-4(3H )-one (5f)
3-{3-[4-(tert -Butyl)phenyl]-3-oxopropyl}quinazolin-4(3H )-one (5f)
Yield 0.194 g, 79%; pale yellow solid; mp 148–150 °C.
1 H NMR (300 MHz, CDCl3 ): δ = 8.29 (s, 1 H), 8.20–8.14 (m, 1 H), 7.78 (d, J = 8.5 Hz, 2 H), 7.65–7.57 (m, 2 H), 7.35 (dd, J = 8.2, 5.2 Hz, 3 H), 4.33 (t, J = 5.9 Hz, 2 H), 3.47 (t, J = 5.9 Hz, 2 H), 1.20 (s, 9 H).
13 C NMR (101 MHz, CDCl3 ): δ = 197.13, 161.39, 157.48, 148.19, 147.76, 134.20, 133.64, 128.07, 127.52, 127.09, 126.39, 125.65, 122.02, 42.86, 36.77, 35.16, 31.04.
HRMS (ESI): m/z calcd for C21 H23 N2 O2 [M + H]: 335.1760; found: 335.1756.
3-[3-(3-Methoxyphenyl)-3-oxopropyl]quinazolin-4(3H )-one (5g)
3-[3-(3-Methoxyphenyl)-3-oxopropyl]quinazolin-4(3H )-one (5g)
Yield 0.190 g, 84%; off-white solid; mp 103–105 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.38 (s, 1 H), 8.29 (dd, J = 8.0, 0.9 Hz, 1 H), 7.77–7.69 (m, 2 H), 7.54–7.48 (m, 2 H), 7.47–7.44 (m, 1 H), 7.34 (t, J = 7.9 Hz, 1 H), 7.10 (ddd, J = 8.2, 2.6, 0.8 Hz, 1 H), 4.42 (t, J = 5.9 Hz, 2 H), 3.83 (s, 3 H), 3.58 (t, J = 5.9 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 197.37, 161.43, 159.89, 148.18, 147.71, 137.47, 134.29, 129.74, 127.54, 127.19, 126.42, 122.02, 120.78, 120.35, 112.08, 55.48, 42.88, 37.01, 29.73.
HRMS (ESI): m/z calcd for C18 H17 N2 O3 [M + H]: 309.1239; found: 309.1241.
3-[3-Oxo-3-(3,4,5-trimethoxyphenyl)propyl]quinazolin-4(3H )-one (5h)
3-[3-Oxo-3-(3,4,5-trimethoxyphenyl)propyl]quinazolin-4(3H )-one (5h)
Yield 0.216 g, 80%; light yellow solid; mp 145–148 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.38 (s, 1 H), 8.29 (d, J = 7.4 Hz, 1 H), 7.75 (ddd, J = 14.0, 10.5, 4.2 Hz, 2 H), 7.52–7.46 (m, 1 H), 7.20 (s, 2 H), 4.43 (t, J = 5.9 Hz, 2 H), 3.89 (s, 9 H), 3.56 (t, J = 5.9 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 196.32, 161.49, 153.14, 148.17, 147.67, 143.08, 134.37, 131.36, 127.57, 127.25, 126.40, 121.99, 105.55, 60.99, 56.34, 43.05, 36.74.
HRMS (ESI): m/z calcd for C20 H21 N2 O5 [M + H]: 369.1450; found: 369.1447.
3-[3-(4-Hydroxyphenyl)-3-oxopropyl]quinazolin-4(3H )-one (5i)
3-[3-(4-Hydroxyphenyl)-3-oxopropyl]quinazolin-4(3H )-one (5i)
Yield 0.168 g, 78%; white solid; mp 200–202 °C.
1 H NMR (300 MHz, CDCl3 + DMSO): δ = 9.63 (s, 1 H), 7.98 (s, 1 H), 7.77 (d, J = 7.9 Hz, 1 H), 7.34 (dd, J = 21.7, 7.9 Hz, 3 H), 7.22 (d, J = 8.0 Hz, 1 H), 7.05 (t, J = 7.4 Hz, 1 H), 6.39 (d, J = 8.5 Hz, 2 H), 3.94 (t, J = 6.1 Hz, 2 H), 3.06 (t, J = 6.1 Hz, 2 H).
13 C NMR (75 MHz, CDCl3 + DMSO): δ = 200.64, 167.49, 165.72, 153.04, 138.92, 135.31, 132.86, 132.17, 131.73, 131.02, 126.78, 120.31, 83.83, 83.39, 82.96, 47.67, 41.21.
HRMS (ESI): m/z calcd for C17 H15 N2 O3 [M + H]: 295.1083; found: 295.1083.
3-[3-(4-Hydroxy-3-methylphenyl)-3-oxopropyl]quinazolin-4(3H )-one (5j)
3-[3-(4-Hydroxy-3-methylphenyl)-3-oxopropyl]quinazolin-4(3H )-one (5j)
Yield 0.172 g, 76%; off-white solid; mp 238–240 °C.
1 H NMR (400 MHz, DMSO): δ = 9.98 (s, 1 H), 8.40 (s, 1 H), 8.21 (d, J = 7.9 Hz, 1 H), 7.75 (t, J = 7.6 Hz, 1 H), 7.69 (s, 1 H), 7.67–7.61 (m, 2 H), 7.49 (t, J = 7.5 Hz, 1 H), 6.83 (d, J = 8.3 Hz, 1 H), 4.37 (t, J = 6.0 Hz, 2 H), 3.48 (t, J = 6.0 Hz, 2 H), 2.17 (s, 3 H).
13 C NMR (101 MHz, DMSO): δ = 196.08, 161.00, 148.29, 134.19, 131.30, 128.02, 127.96, 127.42, 127.00, 126.28, 124.66, 122.03, 114.64, 42.99, 36.44, 16.21.
HRMS (ESI): m/z calcd for C18 H17 N2 O3 [M + H]: 309.1239; found: 309.1239.
3-[3-Oxo-3-(4-phenoxyphenyl)propyl]quinazolin-4(3H )-one (5k)
3-[3-Oxo-3-(4-phenoxyphenyl)propyl]quinazolin-4(3H )-one (5k)
Yield 0.201 g, 74%; sticky solid.
1 H NMR (500 MHz, CDCl3 ): δ = 8.39 (s, 1 H), 8.29 (d, J = 7.7 Hz, 1 H), 7.92 (d, J = 8.8 Hz, 2 H), 7.76–7.70 (m, 2 H), 7.51–7.46 (m, 1 H), 7.39 (t, J = 7.9 Hz, 2 H), 7.20 (t, J = 7.4 Hz, 1 H), 7.04 (d, J = 7.8 Hz, 2 H), 6.97 (d, J = 8.8 Hz, 2 H), 4.42 (t, J = 5.9 Hz, 2 H), 3.54 (t, J = 5.9 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 196.02, 162.52, 161.47, 155.26, 148.16, 147.78, 134.32, 130.81, 130.44, 130.11, 127.54, 127.21, 126.44, 124.80, 122.02, 120.28, 117.33, 42.95, 36.63, 29.73.
HRMS (ESI): m/z calcd for C23 H19 N2 O3 [M + H]: 371.1396; found: 371.1394.
3-[3-(4-Chlorophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5l)
3-[3-(4-Chlorophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5l)
Yield 0.169 g, 74%; off-white solid; mp 130–133 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.37 (s, 1 H), 8.28 (dd, J = 8.0, 1.0 Hz, 1 H), 7.90–7.84 (m, 2 H), 7.77–7.68 (m, 2 H), 7.49 (ddd, J = 8.2, 6.8, 1.5 Hz, 1 H), 7.43–7.38 (m, 2 H), 4.42 (t, J = 5.9 Hz, 2 H), 3.56 (t, J = 5.9 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 196.33, 161.44, 148.15, 147.62, 140.20, 134.44, 134.34, 129.49, 129.07, 127.55, 127.24, 126.40, 121.97, 42.79, 36.84.
HRMS (ESI): m/z calcd for C17 H14 ClN2 O2 [M + H]: 313.0712; found: 313.0739.
3-[3-(3-Chlorophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5m)
3-[3-(3-Chlorophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5m)
Yield 0.165 g, 72%; white solid; mp 145–148 °C.
1 H NMR (500 MHz, CDCl3 ): δ = 8.36 (s, 1 H), 8.28 (dd, J = 8.0, 1.0 Hz, 1 H), 7.90 (t, J = 1.7 Hz, 1 H), 7.81 (d, J = 7.8 Hz, 1 H), 7.77–7.72 (m, 1 H), 7.70 (d, J = 7.4 Hz, 1 H), 7.54–7.46 (m, 2 H), 7.38 (t, J = 7.9 Hz, 1 H), 4.42 (t, J = 5.9 Hz, 2 H), 3.58 (t, J = 5.9 Hz, 2 H).
13 C NMR (126 MHz, CDCl3 ): δ = 196.32, 161.45, 148.17, 147.58, 137.60, 135.15, 134.36, 133.61, 130.09, 128.23, 127.58, 127.26, 126.41, 126.18, 121.98, 42.73, 36.99.
HRMS (ESI): m/z calcd for C17 H14 ClN2 O2 [M + H]: 313.0712; found: 313.0739.
3-[3-(3,4-Dichlorophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5n)
3-[3-(3,4-Dichlorophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5n)
Yield 0.178 g, 70%; pale yellow solid; mp 160–163 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.35 (s, 1 H), 8.30–8.26 (m, 1 H), 8.02 (d, J = 2.0 Hz, 1 H), 7.77–7.73 (m, 2 H), 7.73–7.69 (m, 1 H), 7.55–7.47 (m, 2 H), 4.41 (t, J = 5.9 Hz, 2 H), 3.56 (t, J = 5.9 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 195.40, 161.47, 148.18, 147.47, 138.39, 135.60, 134.40, 133.57, 130.90, 130.13, 127.62, 127.31, 127.07, 126.41, 121.96, 42.71, 36.91.
HRMS (ESI): m/z calcd for C17 H13 N2 O2 Cl2 [M + H]: 347.0354; found: 347.0356.
3-[3-(4-Bromophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5o)
3-[3-(4-Bromophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5o)
Yield 0.180 g, 69%; off-white solid; mp 142–144 °C.
1 H NMR (500 MHz, CDCl3 ): δ = 8.36 (s, 1 H), 8.28 (d, J = 7.8 Hz, 1 H), 7.82–7.69 (m, 4 H), 7.59 (d, J = 8.3 Hz, 2 H), 7.49 (t, J = 7.2 Hz, 1 H), 4.42 (t, J = 5.6 Hz, 2 H), 3.56 (t, J = 5.6 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 196.54, 161.46, 148.18, 147.60, 134.84, 134.36, 132.09, 129.59, 129.00, 127.58, 127.26, 126.41, 121.99, 42.78, 36.83.
HRMS (ESI): m/z calcd for C17 H14 N2 O2 Br [M + H]: 357.0239; found: 357.0249.
3-[3-(3-Bromophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5p)
3-[3-(3-Bromophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5p)
Yield 0.188 g, 72%; pale white solid; mp 139–142 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.36 (s, 1 H), 8.28 (d, J = 7.9 Hz, 1 H), 8.06 (s, 1 H), 7.85 (d, J = 7.9 Hz, 1 H), 7.71 (ddd, J = 18.3, 8.3, 1.1 Hz, 3 H), 7.52–7.46 (m, 1 H), 7.32 (t, J = 7.9 Hz, 1 H), 4.42 (t, J = 5.9 Hz, 2 H), 3.57 (t, J = 5.9 Hz, 2 H).
13 C NMR (126 MHz, CDCl3 ): δ = 196.24, 161.46, 148.16, 147.59, 137.79, 136.54, 134.37, 131.20, 130.34, 127.58, 127.27, 126.62, 126.42, 123.13, 121.98, 77.32, 77.07, 76.81, 42.74, 36.96.
HRMS (ESI): m/z calcd for C17 H14 N2 O2 Br [M + H]: 357.0239; found: 357.0249.
3-[3-(4-Fluorophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5q)
3-[3-(4-Fluorophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5q)
Yield 0.145 g, 67%; white solid; mp 138–141 °C.
1 H NMR (300 MHz, CDCl3 ): δ = 8.38 (s, 1 H), 8.29 (d, J = 8.1 Hz, 1 H), 7.97 (dd, J = 8.7, 5.4 Hz, 2 H), 7.75 (dt, J = 16.6, 4.7 Hz, 2 H), 7.50 (dd, J = 10.6, 4.0 Hz, 1 H), 7.12 (t, J = 8.6 Hz, 2 H), 4.43 (t, J = 5.9 Hz, 2 H), 3.57 (t, J = 5.9 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 195.93, 167.34, 164.80, 161.47, 148.18, 147.66, 134.35, 132.63, 130.85, 130.76, 127.58, 127.24, 126.41, 122.00, 116.02, 115.81, 42.85, 36.78.
HRMS (ESI): m/z calcd for C17 H14 N2 O2 F [M + H]: 297.1039; found: 297.1021.
3-{3-Oxo-3-[3-(trifluoromethyl)phenyl]propyl}quinazolin-4(3H )-one (5r)
3-{3-Oxo-3-[3-(trifluoromethyl)phenyl]propyl}quinazolin-4(3H )-one (5r)
Yield 0.190 g, 75%; off-white solid; mp 120–123 °C.
1 H NMR (500 MHz, CDCl3 ): δ = 8.38 (s, 1 H), 8.28 (dd, J = 8.0, 1.0 Hz, 1 H), 8.05 (d, J = 8.2 Hz, 2 H), 7.74–7.70 (m, 4 H), 7.52–7.48 (m, 1 H), 4.43 (d, J = 5.9 Hz, 2 H), 3.63 (t, J = 5.9 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 196.65, 161.47, 148.13, 147.54, 138.68, 134.42, 128.47, 127.57, 127.32, 126.42, 125.86, 125.83, 121.96, 42.75, 37.18.
HRMS (ESI): m/z calcd for C18 H14 N2 O2 F3 [M + H]: 347.1007; found: 347.1003.
3-[3-(4-Nitrophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5s)
3-[3-(4-Nitrophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5s)
Yield 0.161 g, 68%; pale yellow solid; mp 110–112 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.38 (s, 1 H), 8.28 (dd, J = 7.8, 6.1 Hz, 3 H), 8.10 (d, J = 8.8 Hz, 2 H), 7.78–7.74 (m, 1 H), 7.71 (d, J = 7.4 Hz, 1 H), 7.52–7.47 (m, 1 H), 4.45 (t, J = 5.9 Hz, 2 H), 3.66 (t, J = 5.9 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 196.16, 161.44, 150.62, 148.08, 147.48, 140.35, 134.47, 129.18, 127.55, 127.37, 126.39, 123.98, 121.90, 42.71, 37.41.
HRMS (ESI): m/z calcd for C17 H14 N3 O4 [M + H]: 324.0984; found: 324.0977.
3-[3-(3-Methoxy-4-nitrophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5t)
3-[3-(3-Methoxy-4-nitrophenyl)-3-oxopropyl]quinazolin-4(3H )-one (5t)
Yield 0.181 g, 70%; off-white solid; mp 156–158 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.41 (d, J = 2.2 Hz, 1 H), 8.37 (s, 1 H), 8.28 (dd, J = 8.0, 1.0 Hz, 1 H), 8.14 (dd, J = 8.8, 2.2 Hz, 1 H), 7.77–7.68 (m, 2 H), 7.49 (ddd, J = 8.1, 7.0, 1.4 Hz, 1 H), 7.14 (d, J = 8.9 Hz, 1 H), 4.43 (t, J = 5.9 Hz, 2 H), 4.02 (s, 3 H), 3.58 (t, J = 5.9 Hz, 2 H).
13 C NMR (126 MHz, CDCl3 ): δ = 194.46, 161.45, 156.55, 148.10, 147.59, 139.42, 134.41, 133.83, 128.61, 127.54, 127.31, 126.41, 125.97, 121.94, 113.41, 56.99, 42.75, 36.66.
HRMS (ESI): m/z calcd for C18 H16 N3 O5 [M + H]: 354.1090; found: 354.1086.
3-{3-[(1,1′-Biphenyl)-4-yl]-3-oxopropyl}quinazolin-4(3H )-one (5u)
3-{3-[(1,1′-Biphenyl)-4-yl]-3-oxopropyl}quinazolin-4(3H )-one (5u)
Yield 0.200 g, 77%; pale orange solid; mp 160–162 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.40 (s, 1 H), 8.30 (dd, J = 8.0, 0.8 Hz, 1 H), 8.01 (d, J = 8.5 Hz, 2 H), 7.72 (ddd, J = 9.4, 7.4, 1.4 Hz, 2 H), 7.66 (d, J = 8.5 Hz, 2 H), 7.62–7.58 (m, 2 H), 7.47 (ddd, J = 12.4, 5.3, 3.8 Hz, 3 H), 7.40 (dd, J = 5.5, 1.8 Hz, 1 H), 4.45 (t, J = 5.9 Hz, 2 H), 3.62 (t, J = 5.9 Hz, 2 H).
13 C NMR (126 MHz, CDCl3 ): δ = 197.10, 161.49, 148.21, 147.73, 146.37, 139.66, 134.84, 134.31, 128.99, 128.72, 128.39, 127.57, 127.36, 127.29, 127.21, 126.44, 122.04, 42.90, 36.93.
HRMS (ESI): m/z calcd for C23 H19 N2 O2 [M + H]: 355.1447; found: 355.1448.
3-[3-(Furan-2-yl)-3-oxopropyl]quinazolin-4(3H )-one (5v)
3-[3-(Furan-2-yl)-3-oxopropyl]quinazolin-4(3H )-one (5v)
Yield 0.159 g, 81%; white solid; mp 160–162 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.32 (s, 1 H), 8.29 (d, J = 8.1 Hz, 1 H), 7.77–7.66 (m, 2 H), 7.56 (s, 1 H), 7.49 (t, J = 7.4 Hz, 1 H), 7.22 (d, J = 3.5 Hz, 1 H), 6.52 (dd, J = 3.5, 1.5 Hz, 1 H), 4.40 (t, J = 6.0 Hz, 2 H), 3.45 (t, J = 6.0 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 186.37, 161.40, 152.14, 148.18, 147.53, 146.89, 134.31, 127.57, 127.21, 126.44, 122.02, 117.89, 112.47, 42.33, 36.74.
HRMS (ESI): m/z calcd for C15 H13 N2 O3 [M + H]: 269.0926; found: 269.0932.
3-[3-Oxo-3-(thiophen-2-yl)propyl]quinazolin-4(3H )-one (5w)
3-[3-Oxo-3-(thiophen-2-yl)propyl]quinazolin-4(3H )-one (5w)
Yield 0.171 g, 82%; pale yellow solid; mp 110–112 °C.
1 H NMR (500 MHz, CDCl3 ): δ = 8.33 (s, 1 H), 8.29 (dd, J = 8.0, 1.0 Hz, 1 H), 7.76–7.69 (m, 3 H), 7.64 (dd, J = 4.9, 0.9 Hz, 1 H), 7.51–7.47 (m, 1 H), 7.10 (dd, J = 4.8, 4.0 Hz, 1 H), 4.41 (t, J = 5.9 Hz, 2 H), 3.54 (t, J = 6.0 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 190.31, 161.44, 148.20, 147.59, 143.32, 134.42, 134.33, 132.61, 128.32, 127.59, 127.22, 126.42, 122.00, 42.75, 42.70, 37.46.
HRMS (ESI): m/z calcd for C15 H13 N2 O2 S [M + H]: 285.0698; found: 285.0688.
3-(3-{Benzo[d ][1,3]dioxol-5-yl}-3-oxopropyl)quinazolin-4(3H )-one (5x)
3-(3-{Benzo[d ][1,3]dioxol-5-yl}-3-oxopropyl)quinazolin-4(3H )-one (5x)
Yield 0.189 g, 80%; off-white solid; mp 163–165 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.37 (s, 1 H), 8.28 (dd, J = 8.0, 0.9 Hz, 1 H), 7.75–7.68 (m, 2 H), 7.53 (dd, J = 8.2, 1.7 Hz, 1 H), 7.48 (ddd, J = 8.2, 6.9, 1.5 Hz, 1 H), 7.40 (d, J = 1.7 Hz, 1 H), 6.81 (d, J = 8.2 Hz, 1 H), 6.02 (s, 2 H), 4.41 (t, J = 5.9 Hz, 2 H), 3.51 (t, J = 5.9 Hz, 2 H).
13 C NMR (126 MHz, CDCl3 ): δ = 195.48, 161.45, 152.23, 148.30, 148.17, 147.73, 134.28, 131.06, 127.53, 127.17, 126.41, 124.61, 122.00, 107.97, 107.73, 101.96, 42.99, 36.60.
HRMS (ESI): m/z calcd for C18 H15 N2 O4 [M + H]: 323.1032; found: 323.1033.
3-[3-(Naphthalen-2-yl)-3-oxopropyl]quinazolin-4(3H )-one (5y)
3-[3-(Naphthalen-2-yl)-3-oxopropyl]quinazolin-4(3H )-one (5y)
Yield 0.176 g, 73%; pale white solid; mp 110–112 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.46 (s, 1 H), 8.43 (s, 1 H), 8.30 (d, J = 7.9 Hz, 1 H), 8.00 (dd, J = 8.6, 1.3 Hz, 1 H), 7.93 (d, J = 8.0 Hz, 1 H), 7.89–7.83 (m, 2 H), 7.72 (t, J = 8.2 Hz, 2 H), 7.59 (dd, J = 14.3, 7.2 Hz, 2 H), 7.53–7.46 (m, 1 H), 4.49 (t, J = 5.8 Hz, 2 H), 3.74 (t, J = 5.9 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 197.46, 196.23, 161.50, 161.32, 148.14, 147.78, 147.28, 141.69, 135.80, 135.36, 134.44, 134.32, 134.14, 133.48, 132.42, 132.16, 131.31, 130.45, 130.15, 129.64, 129.44, 128.80, 128.64, 128.52, 127.80, 127.61, 127.51, 127.39, 127.22, 126.96, 126.66, 126.42, 125.15, 123.47, 122.11, 122.02, 42.99, 42.69, 36.94.
HRMS (ESI): m/z calcd for C21 H17 N2 O2 [M + H]: 329.1290; found: 329.1288.
3-[3-(Anthracen-2-yl)-3-oxopropyl]quinazolin-4(3H )-one (5z)
3-[3-(Anthracen-2-yl)-3-oxopropyl]quinazolin-4(3H )-one (5z)
Yield 0.216 g, 78%; off-white solid; mp 131–133 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.39 (s, 1 H), 8.36 (s, 1 H), 8.23 (d, J = 7.4 Hz, 1 H), 7.92 (d, J = 8.5 Hz, 2 H), 7.74–7.68 (m, 2 H), 7.49–7.43 (m, 3 H), 7.38–7.33 (m, 2 H), 7.29–7.23 (m, 2 H), 4.51 (t, J = 6.1 Hz, 2 H), 3.55 (t, J = 6.1 Hz, 2 H).
13 C NMR (101 MHz, CDCl3): δ = 208.14, 161.28, 148.08, 147.56, 134.93, 134.49, 134.17, 130.93, 128.94, 128.79, 127.56, 127.42, 127.24, 127.12, 126.79, 126.54, 125.57, 123.58, 121.95, 44.19, 42.76, 42.68.
HRMS (ESI): m/z calcd for C25 H19 N2 O2 [M + H]: 379.1447; found: 379.1450.
6-Chloro-3-(3-oxo-3-phenylpropyl)quinazolin-4(3H )-one (5ba)
6-Chloro-3-(3-oxo-3-phenylpropyl)quinazolin-4(3H )-one (5ba)
Yield 0.131 g, 72%; off-white solid; mp 138–140 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.75 (s, 1 H), 8.24 (d, J = 13.8 Hz, 1 H), 7.92 (s, 1 H), 7.84 (s, 1 H), 7.71 (s, 1 H), 7.56 (s, 1 H), 7.45 (d, J = 6.8 Hz, 2 H), 7.24 (d, J = 15.3 Hz, 1 H), 4.49 (s, 2 H), 3.61 (s, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 197.45, 162.28, 160.76, 159.81, 147.10, 144.86, 136.07, 133.74, 130.02, 129.94, 128.76, 128.09, 122.98, 122.74, 111.42, 111.18, 42.89, 36.74.
HRMS (ESI): m/z calcd for C17 H14 ClN2 O2 [M + H]: 313.0712; found: 313.0739.
6-Fluoro-3-(3-oxo-3-phenylpropyl)quinazolin-4(3H )-one (5ca)
6-Fluoro-3-(3-oxo-3-phenylpropyl)quinazolin-4(3H )-one (5ca)
Yield 0.144 g, 75%; off-white solid; mp 144–146 °C.
1 H NMR (400 MHz, CDCl3 ): δ = 8.53 (s, 1 H), 7.85 (td, J = 7.5, 3.9 Hz, 3 H), 7.75 (dd, J = 8.7, 4.7 Hz, 1 H), 7.49 (d, J = 7.4 Hz, 1 H), 7.41 (dd, J = 2.9, 0.8 Hz, 1 H), 7.38 (dd, J = 9.9, 5.3 Hz, 2 H), 4.41 (t, J = 5.7 Hz, 2 H), 3.54 (t, J = 5.8 Hz, 2 H).
13 C NMR (101 MHz, CDCl3 ): δ = 197.45, 162.28, 160.76, 159.81, 147.10, 144.86, 136.07, 133.74, 130.02, 129.94, 128.76, 128.09, 122.98, 122.74, 111.42, 111.18, 42.89, 36.74.
HRMS (ESI): m/z calcd for C17 H14 N2 O2 F [M + H]: 297.1039; found: 297.1021.
Quinazolin-4(3H )-one (3a)
Quinazolin-4(3H )-one (3a)
1 H NMR (500 MHz, CDCl3 ): δ = 11.96 (s, 1 H), 8.27 (d, J = 8.0 Hz, 1 H), 8.02 (s, 1 H), 7.85–7.69 (m, 2 H), 7.50 (dd, J = 10.6, 4.0 Hz, 1 H).
13 C NMR (126 MHz, CDCl3 ): δ = 162.82, 148.91, 143.38, 135.00, 127.84, 127.53, 126.44, 122.57.
3-(3-Oxo-3-phenylpropyl-1,1-d
2 )quinazolin-4(3H )-one-2-d (5a-d
3 )
3-(3-Oxo-3-phenylpropyl-1,1-d
2 )quinazolin-4(3H )-one-2-d (5a-d
3 )
1 H NMR (500 MHz, CDCl3 ): δ = 8.29 (d, J = 7.9 Hz, 1 H), 7.94 (d, J = 7.6 Hz, 2 H), 7.77–7.69 (m, 2 H), 7.56 (t, J = 7.4 Hz, 1 H), 7.50 (d, J = 7.3 Hz, 1 H), 7.44 (t, J = 7.7 Hz, 2 H), 3.57 (d, J = 16.4 Hz, 2 H).
